Tech Company Financing Transactions
Avaxia Biologics Funding Round
Avaxia Biologics, based in Lexington, secured $2.2 million from Cherrystone Angel Group, Boston Harbor Angels and private investors.
Transaction Overview
Company Name
Announced On
11/10/2011
Transaction Type
Venture Equity
Amount
$2,200,000
Round
Series A
Investors
Cherrystone Angel Group (Lead Investor) (Robert Manning)
Proceeds Purpose
This investment will allow us to aggressively pursue the development of our AVX-470 anti-TNF oral antibody and prepare Avaxia to initiate a clinical trial in inflammatory bowel disease next fall.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
128 Spring St. 620
Lexington, MA 02421
USA
Lexington, MA 02421
USA
Phone
Website
Email Address
Overview
Avaxia Biologics develops orally-delivered antibody therapeutics using a proprietary antibody platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Barbara Fox
Chief Financial Officer
David Neafus
VP - Operations
Neil Schauer
Browse more venture capital transactions:
Prev: 11/10/2011: Any.do venture capital transaction
Next: 11/10/2011: ScribbleLive venture capital transaction
Share this article
About Our VC Transactions Data
We record every notable VC transaction. All VC database entries on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs